152 related articles for article (PubMed ID: 9838243)
1. Hypercalcemia in malignant paraganglioma due to parathyroid hormone-related protein.
Loh K; Matthay KK; Hoover M; Bracho FA; Cortez AB; Conte FA; Albanese CT; Miller TR; Price DC; Flores AJ; Kaviani A; Shoback D
Horm Res; 1998; 50(4):217-21. PubMed ID: 9838243
[TBL] [Abstract][Full Text] [Related]
2. Parathyroid hormone-related protein (PTHrP) does not regulate 1,25-dihydroxyvitamin D serum levels in hypercalcemia of malignancy.
Schilling T; Pecherstorfer M; Blind E; Leidig G; Ziegler R; Raue F
J Clin Endocrinol Metab; 1993 Mar; 76(3):801-3. PubMed ID: 8445039
[TBL] [Abstract][Full Text] [Related]
3. Circulating PTH and PTHrP levels before and after treatment of tumor induced hypercalcemia with Pamidronate Disodium (APD).
Grill V; Murray RM; Ho PW; Santamaria JD; Pitt P; Potts C; Jerums G; Martin TJ
J Clin Endocrinol Metab; 1992 Jun; 74(6):1468-70. PubMed ID: 1592895
[TBL] [Abstract][Full Text] [Related]
4. Circulating PTHrP concentrations in tumor-induced hypercalcemia: influence on the response to bisphosphonate and changes after therapy.
Body JJ; Dumon JC; Thirion M; Cleeren A
J Bone Miner Res; 1993 Jun; 8(6):701-6. PubMed ID: 8328312
[TBL] [Abstract][Full Text] [Related]
5. 1,25-dihydroxyvitamin D and PTHrP mediated malignant hypercalcemia in a seminoma.
Rodríguez-Gutiérrez R; Zapata-Rivera MA; Quintanilla-Flores DL; Camara-Lemarroy CR; Lavalle-Gonzalez FJ; González-González JG; Villarreal-Pérez JZ
BMC Endocr Disord; 2014 Apr; 14():32. PubMed ID: 24721620
[TBL] [Abstract][Full Text] [Related]
6. The role of 1,25-dihydroxyvitamin D in the maintenance of hypercalcemia in a patient with an ovarian carcinoma producing parathyroid hormone-related protein.
Hoekman K; Tjandra YI; Papapoulos SE
Cancer; 1991 Aug; 68(3):642-7. PubMed ID: 2065286
[TBL] [Abstract][Full Text] [Related]
7. Hypercalcemia due to sun exposure in a patient with multiple myeloma and elevated parathyroid hormone-related protein.
Papapetrou PD; Bergi-Stamatelou M; Karga H; Thanou S
Eur J Endocrinol; 2003 Mar; 148(3):351-5. PubMed ID: 12611617
[TBL] [Abstract][Full Text] [Related]
8. Hypercalcemia mediated by parathyroid hormone-related protein as an early manifestation of pancreatic adenocarcinoma metastasis: a case report.
Rasnake MS; Glanton C; Ornstein D; Osswald M; Garrison M
Am J Clin Oncol; 2001 Aug; 24(4):416-7. PubMed ID: 11474277
[TBL] [Abstract][Full Text] [Related]
9. Levels of parathyroid hormone-related protein (PTHrP) in hypercalcemia of malignancy are not lowered by treatment with the bisphosphonate BM 21.0955.
Blind E; Raue F; Meinel T; Wüster C; Ziegler R
Horm Metab Res; 1993 Jan; 25(1):40-4. PubMed ID: 8428711
[TBL] [Abstract][Full Text] [Related]
10. Effects of treatment of malignancy-associated hypercalcemia on serum parathyroid hormone-related protein.
Budayr AA; Zysset E; Jenzer A; Thiébaud D; Ammann P; Rizzoli R; Jaquet-Müller F; Bonjour JP; Gertz B; Burckhardt P
J Bone Miner Res; 1994 Apr; 9(4):521-6. PubMed ID: 8030440
[TBL] [Abstract][Full Text] [Related]
11. Parathyroid hormone and parathyroid hormone related protein assays in the investigation of hypercalcemic patients in hospital in a Chinese population.
Lee JK; Chuang MJ; Lu CC; Hao LJ; Yang CY; Han TM; Lam HC
J Endocrinol Invest; 1997; 20(7):404-9. PubMed ID: 9309539
[TBL] [Abstract][Full Text] [Related]
12. Pamidronate treatment in patients with tumor-associated hypercalcemia: pharmacological effects and pharmacokinetics.
Oiso Y; Tomita A; Hasegawa H; Ariyoshi Y; Niinomi M; Yamamoto M; Takano T; Sakiyama N
Endocr J; 1994 Dec; 41(6):655-61. PubMed ID: 7704089
[TBL] [Abstract][Full Text] [Related]
13. Elevated parathyroid hormone-related peptide in a patient with an extragonadal germ-cell tumour and hypercalcemia.
Sorscher S
Can J Surg; 2004 Apr; 47(2):144. PubMed ID: 15132472
[No Abstract] [Full Text] [Related]
14. Hypercalcemia and local production of parathyroid hormone-related protein by a perisellar rhabdomyosarcoma after remote pituitary irradiation.
Florez JC; Burton DW; Arnell PM; Deftos LJ; Klibanski A
Endocr Pract; 2005; 11(3):184-9. PubMed ID: 16239205
[TBL] [Abstract][Full Text] [Related]
15. Hypercalcemia associated with squamous cell carcinoma of tongue.
Gavrila A; Hasinski S; Rose LI
Endocr Pract; 2001; 7(6):459-62. PubMed ID: 11747283
[TBL] [Abstract][Full Text] [Related]
16. Serum parathyroid hormone-related protein levels and response to bisphosphonate treatment in hypercalcemia of malignancy.
Rizzoli R; Thiébaud D; Bundred N; Pecherstorfer M; Herrmann Z; Huss HJ; Rückert F; Manegold C; Tubiana-Hulin M; Steinhauer EU; Degardin M; Thürlimann B; Clemens MR; Eghbali H; Body JJ
J Clin Endocrinol Metab; 1999 Oct; 84(10):3545-50. PubMed ID: 10522993
[TBL] [Abstract][Full Text] [Related]
17. Megakaryoblastic transformation of polycythemia vera with hypercalcemia.
Kurosawa M; Iwasaki H
Ann Hematol; 2002 Nov; 81(11):668-71. PubMed ID: 12454709
[TBL] [Abstract][Full Text] [Related]
18. Parathyroid hormone-related protein as a potential tumor marker: a case report of ovarian clear cell carcinoma.
Suwaki N; Masuyama H; Mizutani Y; Kodama J; Hiramatsu Y
J Obstet Gynaecol Res; 2006 Feb; 32(1):94-8. PubMed ID: 16445533
[TBL] [Abstract][Full Text] [Related]
19. Parathyroid hormone (PTH)-related protein, PTH, and 1,25-dihydroxyvitamin D in dogs with cancer-associated hypercalcemia.
Rosol TJ; Nagode LA; Couto CG; Hammer AS; Chew DJ; Peterson JL; Ayl RD; Steinmeyer CL; Capen CC
Endocrinology; 1992 Sep; 131(3):1157-64. PubMed ID: 1505457
[TBL] [Abstract][Full Text] [Related]
20. Tumor induced hypercalcemia in a patient with mediastinal synovial sarcoma.
Vakili R; Hiradfar M; Zabolinejad N; Badiei Z
J Pediatr Endocrinol Metab; 2007 Jul; 20(7):841-5. PubMed ID: 17849748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]